investigational participated study device participating currently agent weeks therapy dose 
received prior therapy patients treatment previously systemic days study weeks 
patients eligible study excluded therapy prior treated treatment receiving receive 
participant research study received treatment therapy prior disease receiving investigator 
concurrently investigational receiving agents study patients therapy treatment agent using 
drug study dose days administration prior weeks investigational therapy experimental 
agents investigational receiving patients currently participants study anti eligible cancer 
investigational agent days treatment study prior weeks received drug receiving 
